<h1>VJ Group Unveils VJ Bio to Revolutionize Affordable Therapies with New R&D Center and Plasmid DNA Services</h1> VJ Group launched VJ Bio, a biotech company aimed at creating an integrated ecosystem for developing affordable next-generation therapies, at the 5th Annual Summit of Biologics Conferences in Goa. The company focuses on five key pillars: supply chain, manufacturing, delivery vehicles, genetic payloads, and analytics. Their first milestone is the launch of plasmid DNA manufacturing services. VJ Biosciences, a subsidiary in India, received the Make in India excellence award and is expanding its R&D center near Bangalore. The facility will adhere to local and international regulatory standards, enhancing their capabilities in cell and gene therapy development.